Clinical Trial Update: Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Imatinib Mesylate with or without Interferon Alfa or Cytarabine versus Interferon Alfa followed by donor stem cell transplant in newly …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Imatinib mesylate (Imatinib)
• Interferon Alfa (interferon alfa)

Snippet

Sponsor: Heidelberg University | Conditions: Leukemia | Phase 3 | Status: COMPLETED